Myeloid-Derived Suppressor Cells as Effectors of Immune Suppression in Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.30232
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

Frontiers in Immunology
AllergyImmunology
2018English

Myeloid-Derived Suppressor Cells and Myeloid Regulatory Cells in Cancer and Autoimmune Disorders

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression Through Inhibition of NKT Cell Function

Frontiers in Immunology
AllergyImmunology
2017English

Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications

Seminars in Oncology
OncologyHematology
2014English

Myeloid-Derived Suppressor Cells in Autoimmune Diseases

Inflammation and Regeneration
AllergyImmunology
2014English

Myeloid Derived Suppressor Cells: Subsets, Expansion, and Role in Cancer Progression

2012English

HMGB1 Promotes Myeloid-Derived Suppressor Cells and Renal Cell Carcinoma Immune Escape

Oncotarget
Oncology
2017English

Tumor-Derived Lactate and Myeloid-Derived Suppressor Cells: Linking Metabolism to Cancer Immunology

OncoImmunology
OncologyAllergyImmunology
2013English

Characterization of Myeloid Leukocytes and Soluble Mediators in Pancreatic Cancer: Importance of Myeloid-Derived Suppressor Cells

OncoImmunology
OncologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy